Global Epilepsy Treatment Drugs Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (First, Second, Third-generation), By Type (Branded, Generic), By Seizure Type (Focal, and Generalized), By Route of Administration (Oral, Nasal, Injectable), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare
RELEASE DATE Apr 2024
REPORT ID SI4172
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Drug Class
      2. Market Attractiveness Analysis By Type
      3. Market Attractiveness Analysis By Seizure Type
      4. Market Attractiveness Analysis By Route of Administration
      5. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Significant cases of epilepsy
      2. Rising awareness of epilepsy and its symptoms and its early diagnosis
      3. Population growth, aging population, and improved diagnosis
    3. Restraints
      1. Reimbursement policies for epilepsy drugs
      2. Associated adverse effects of epileptic drugs
    4. Opportunities
      1. Advancements in antiepileptic drug discovery, including generic versions of antiepileptic drugs
    5. Challenges
      1.  Associated adverse effects of epileptic drugs
  6. Global Epilepsy Treatment Drugs Market Analysis and Projection, By Drug Class
    1. Segment Overview
    2. First-generation
    3. Second-generation
    4. Third-generation

 

  1. Global Epilepsy Treatment Drugs Market Analysis and Projection, By Type
    1. Segment Overview
    2. Branded
    3. Generic

 

  1. Global Epilepsy Treatment Drugs Market Analysis and Projection, By Seizure Type
    1. Segment Overview
    2. Focal
    3. Generalized

 

  1. Global Epilepsy Treatment Drugs Market Analysis and Projection, By Route of Administration
    1. Segment Overview
    2. Oral
    3. Nasal
    4. Injectable

 

  1. Global Epilepsy Treatment Drugs Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  2. Global Epilepsy Treatment Drugs Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Epilepsy Treatment Drugs Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  3. Company Profiles
    1. Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Abbott Laboratories 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  GlaxoSmithKline Plc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   UCB Pharma S.A. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Viatris Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Johnson & Johnson
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Dr. Reddy’s Laboratories
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Sanofi
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Pfizer
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Sun Pharmaceutical Industries, Ltd. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Bausch Health Companies, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Sumitomo Pharma Co. Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  SK Biopharmaceuticals 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  Novel Laboratories Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Neurelis, Inc. 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  2. Global First-generation, Epilepsy Treatment Drugs Market, By Region, 2023-2033(USD Billion)
  3. Global Second-generation, Epilepsy Treatment Drugs Market, By Region, 2023-2033(USD Billion)
  4. Global Third-generation, Epilepsy Treatment Drugs Market, By Region, 2023-2033(USD Billion)
  5. Global Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  6. Global Branded, Epilepsy Treatment Drugs Market, By Region, 2023-2033(USD Billion)
  7. Global Generic, Epilepsy Treatment Drugs Market, By Region, 2023-2033(USD Billion)
  8. Global Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  9. Global Focal, Epilepsy Treatment Drugs Market, By Region, 2023-2033(USD Billion)
  10. Global Generalized, Epilepsy Treatment Drugs Market, By Region, 2023-2033(USD Billion)
  11. Global Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  12. Global Oral, Epilepsy Treatment Drugs Market, By Region, 2023-2033(USD Billion)
  13. Global Nasal, Epilepsy Treatment Drugs Market, By Region, 2023-2033(USD Billion)
  14. Global Injectable, Epilepsy Treatment Drugs Market, By Region, 2023-2033(USD Billion)
  15. North America Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  16. North America Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  17. North America Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  18. North America Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  19. U.S.  Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  20. U.S.  Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  21. U.S.  Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  22. U.S.  Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  23. Canada Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  24. Canada Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  25. Canada Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  26. Canada Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  27. Mexico Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  28. Mexico Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  29. Mexico Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  30. Mexico Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  31. Europe Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  32. Europe Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  33. Europe Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  34. Europe Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  35. Germany Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  36. Germany Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  37. Germany Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  38. Germany Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  39. France Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  40. France Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  41. France Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  42. France Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  43. U.K.  Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  44. U.K.  Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  45. U.K.  Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  46. U.K.  Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  47. Italy Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  48. Italy Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  49. Italy Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  50. Italy Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  51. Spain Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  52. Spain Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  53. Spain Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  54. Spain Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  55. Asia Pacific Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  56. Asia Pacific Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  57. Asia Pacific Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  58. Asia Pacific Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  59. Japan Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  60. Japan Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  61. Japan Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  62. Japan Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  63. China Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  64. China Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  65. China Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  66. China Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  67. India Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  68. India Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  69. India Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  70. India Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  71. South America Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  72. South America Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  73. South America Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  74. South America Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  75. Brazil Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  76. Brazil Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  77. Brazil Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  78. Brazil Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  79. The Middle East and Africa Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD   Billion)
  80. The Middle East and Africa Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD   Billion)
  81. The Middle East and Africa Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  82. The Middle East and Africa Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)
  83. UAE Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  84. UAE Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  85. UAE Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  86. UAE Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion) 
  87. South Africa Epilepsy Treatment Drugs Market, By Drug Class, 2023-2033(USD Billion)
  88. South Africa Epilepsy Treatment Drugs Market, By Type, 2023-2033(USD Billion)
  89. South Africa Epilepsy Treatment Drugs Market, By Seizure Type, 2023-2033(USD Billion)
  90. South Africa Epilepsy Treatment Drugs Market, By Route of Administration, 2023-2033(USD Billion)

List of Figures 

  1. Global Epilepsy Treatment Drugs Market Segmentation
  2. Epilepsy Treatment Drugs Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Epilepsy Treatment Drugs Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Epilepsy Treatment Drugs Market
  20. Epilepsy Treatment Drugs Market Segmentation, By Drug Class
  21. Epilepsy Treatment Drugs Market For First-generation, By Region, 2023-2033 ($ Billion)
  22.  Epilepsy Treatment Drugs Market For Second-generation, By Region, 2023-2033 ($ Billion)
  23. Epilepsy Treatment Drugs Market For Third-generation, By Region, 2023-2033 ($ Billion)
  24. Epilepsy Treatment Drugs Market Segmentation, By Type
  25.  Epilepsy Treatment Drugs Market For Branded, By Region, 2023-2033 ($ Billion)
  26.  Epilepsy Treatment Drugs Market For Generic, By Region, 2023-2033 ($ Billion)
  27. Epilepsy Treatment Drugs Market Segmentation, By Seizure Type
  28. Epilepsy Treatment Drugs Market For Focal, By Region, 2023-2033 ($ Billion)
  29. Epilepsy Treatment Drugs Market For Generalized, By Region, 2023-2033 ($ Billion)
  30. Epilepsy Treatment Drugs Market Segmentation, By Route of Administration
  31. Epilepsy Treatment Drugs Market For Oral, By Region, 2023-2033 ($ Billion)
  32. Epilepsy Treatment Drugs Market For Nasal, By Region, 2023-2033 ($ Billion)
  33. Epilepsy Treatment Drugs Market For Injectable, By Region, 2023-2033 ($ Billion)
  34. Novartis AG: Net Sales, 2023-2033 ($ Billion)
  35. Novartis AG: Revenue Share, By Segment, 2023 (%)
  36. Novartis AG: Revenue Share, By Region, 2023 (%)
  37. Abbott Laboratories: Net Sales, 2023-2033 ($ Billion)
  38. Abbott Laboratories: Revenue Share, By Segment, 2023 (%)
  39. Abbott Laboratories: Revenue Share, By Region, 2023 (%)
  40. GlaxoSmithKline Plc.: Net Sales, 2023-2033 ($ Billion)
  41. GlaxoSmithKline Plc.: Revenue Share, By Segment, 2023 (%)
  42. GlaxoSmithKline Plc.: Revenue Share, By Region, 2023 (%)
  43. UCB Pharma S.A.: Net Sales, 2023-2033 ($ Billion)
  44. UCB Pharma S.A.: Revenue Share, By Segment, 2023 (%)
  45. UCB Pharma S.A.: Revenue Share, By Region, 2023 (%)
  46. Viatris Inc.: Net Sales, 2023-2033 ($ Billion)
  47. Viatris Inc.: Revenue Share, By Segment, 2023 (%)
  48. Viatris Inc.: Revenue Share, By Region, 2023 (%)
  49. Johnson & Johnson: Net Sales, 2023-2033 ($ Billion)
  50. Johnson & Johnson: Revenue Share, By Segment, 2023 (%)
  51. Johnson & Johnson: Revenue Share, By Region, 2023 (%)
  52. Dr. Reddy’s Laboratories: Net Sales, 2023-2033 ($ Billion)
  53. Dr. Reddy’s Laboratories: Revenue Share, By Segment, 2023 (%)
  54. Dr. Reddy’s Laboratories: Revenue Share, By Region, 2023 (%)
  55. Sanofi: Net Sales, 2023-2033 ($ Billion)
  56. Sanofi: Revenue Share, By Segment, 2023 (%)
  57. Sanofi: Revenue Share, By Region, 2023 (%)
  58. Pfizer.: Net Sales, 2023-2033 ($ Billion)
  59. Pfizer.: Revenue Share, By Segment, 2023 (%)
  60. Pfizer.: Revenue Share, By Region, 2023 (%)
  61. Sun Pharmaceutical Industries, Ltd.: Net Sales, 2023-2033 ($ Billion)
  62. Sun Pharmaceutical Industries, Ltd.: Revenue Share, By Segment, 2023 (%)
  63. Sun Pharmaceutical Industries, Ltd.: Revenue Share, By Region, 2023 (%)
  64. Bausch Health Companies, Inc.: Net Sales, 2023-2033 ($ Billion)
  65. Bausch Health Companies, Inc.: Revenue Share, By Segment, 2023 (%)
  66. Bausch Health Companies, Inc.: Revenue Share, By Region, 2023 (%)
  67. Sumitomo Pharma Co. Ltd.: Net Sales, 2023-2033 ($ Billion)
  68. Sumitomo Pharma Co. Ltd.: Revenue Share, By Segment, 2023 (%)
  69. Sumitomo Pharma Co. Ltd.: Revenue Share, By Region, 2023 (%)
  70. SK Biopharmaceuticals: Net Sales, 2023-2033 ($ Billion)
  71. SK Biopharmaceuticals: Revenue Share, By Segment, 2023 (%)
  72. SK Biopharmaceuticals: Revenue Share, By Region, 2023 (%)
  73. Novel Laboratories Inc.: Net Sales, 2023-2033 ($ Billion)
  74. Novel Laboratories Inc.: Revenue Share, By Segment, 2023 (%)
  75. Novel Laboratories Inc.: Revenue Share, By Region, 2023 (%)
  76. Neurelis, Inc.: Net Sales, 2023-2033 ($ Billion)
  77. Neurelis, Inc.: Revenue Share, By Segment, 2023 (%)
  78. Neurelis, Inc.: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:110
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:4.36%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies